FENNEC PHARMACEUTICALS INC.

By person

9 insiders · 32 transactions

1.1×

Jeffrey Hackman holds only 1.1 times base salary in stock. $682.25K of shares against $586.34K in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Hackman last reported holding, valued at $10.29, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Southpoint Capital Advisors LP entity

10% owner

—

$10.34M (7)

−$10.34M

2,744,741

7.83%

$28.24M

−32.7%

Raykov Rosty

Former Director

—

$1.05M (12) scheduled

−$1.05M

124,411

0.3548%

$1.28M

+103.2%

Andrade Robert

CHIEF FINANCIAL OFFICER

—

$883.50K (1) scheduled

−$883.50K

241,306

0.6881%

$2.48M

+120.4%

Brughera Marco Maria

Director

—

$159.96K (1) scheduled

−$159.96K

0.0000%

$0.00

—

Sayad Pierre Sargis

Chief Medical Officer

—

$146.16K (1)

−$146.16K

9,519

0.0271%

$97.95K

—

RALLIS CHRIS A

Director

—

$75.16K (2) scheduled

−$75.16K

63,077

0.1799%

$649.06K

+31.2%

Hackman Jeffrey S.

Chief Executive Officer

—

66,302

0.1891%

$682.25K

—

Cioffi Christiana Marie

Chief Strategy Officer

—

24,644

0.0703%

$253.59K

—

Evans Terry L

Chief Commercial Officer

—

21,519

0.0614%

$221.43K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Brughera Marco Maria

15 Sep 2026

Director

Sold after exercise

15,545

$10.29

$159.96K

Raykov Rosty

1 Sep 2026

Former Director

Sold on a plan

10,000

$12.11

$121.10K

Sayad Pierre Sargis

31 Aug 2026

Chief Medical Officer

Sell

12,000

$12.18

$146.16K

Andrade Robert

28 Aug 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

21,928

$5.10

$111.83K

Andrade Robert

27 Aug 2026

CHIEF FINANCIAL OFFICER

Sold on a plan

75,000

$11.78

$883.50K

Raykov Rosty

3 Aug 2026

Former Director

Sold on a plan

10,000

$9.58

$95.80K

Raykov Rosty

1 Jul 2026

Former Director

Sold after exercise

9,599

$10.41

$99.93K

Raykov Rosty

1 Jun 2026

Director

Sold after exercise

9,747

$9.62

$93.77K

RALLIS CHRIS A

11 May 2026

Director

Sold after exercise

8,346

$7.04

$58.76K

Raykov Rosty

1 May 2026

Director

Sold after exercise

10,781

$6.47

$69.75K

Raykov Rosty

1 Apr 2026

Director

Sold after exercise

10,946

$6.31

$69.07K

Cioffi Christiana Marie

26 Mar 2026

Chief Strategy Officer

Exercised, kept

4,700

$4.23

$19.88K

Andrade Robert

26 Mar 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

13,072

$5.10

$66.67K

Raykov Rosty

2 Mar 2026

Director

Sold after exercise

10,079

$8.36

$84.26K

Andrade Robert

18 Feb 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

2,450

$4.08

$10.00K

Raykov Rosty

2 Feb 2026

Director

Sold after exercise

10,349

$7.76

$80.31K

Andrade Robert

23 Jan 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

10,000

$2.45

$24.50K

Andrade Robert

15 Jan 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

10,000

$2.45

$24.50K

Andrade Robert

7 Jan 2026

CHIEF FINANCIAL OFFICER

Exercised, kept

14,184

$2.45

$34.75K

Raykov Rosty

2 Jan 2026

Director

Sold after exercise

10,312

$7.60

$78.37K

Southpoint Capital Advisors LP

24 Dec 2025

10% owner

Sell indirect

1,000,000

$7.50

$7.50M

Raykov Rosty

5 Dec 2025

Director

Sold on a plan

10,000

$7.54

$75.40K

Southpoint Capital Advisors LP

18 Nov 2025

10% owner

Sell indirect

19,341

$8.79

$170.05K

Southpoint Capital Advisors LP

17 Nov 2025

10% owner

Sell indirect

85,918

$8.79

$755.19K

Southpoint Capital Advisors LP

14 Nov 2025

10% owner

Sell indirect

160,100

$8.00

$1.28M

Raykov Rosty

5 Nov 2025

Director

Sold on a plan

10,000

$8.10

$81.00K

RALLIS CHRIS A

10 Oct 2025

Director

Sold after exercise

1,775

$9.24

$16.40K

Southpoint Capital Advisors LP

9 Oct 2025

10% owner

Sell indirect

20,609

$9.35

$192.61K

Raykov Rosty

8 Oct 2025

Director

Exercised, kept

4,609

$2.45

$11.29K

Southpoint Capital Advisors LP

8 Oct 2025

10% owner

Sell indirect

19,605

$9.47

$185.72K

Southpoint Capital Advisors LP

7 Oct 2025

10% owner

Sell indirect

26,900

$9.59

$257.89K

Raykov Rosty

6 Oct 2025

Director

Sold on a plan

10,000

$9.78

$97.80K

FENNEC PHARMACEUTICALS INC.

By person

Individual transactions

What was left out